Compare Burjeel Holdings Plc with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
AED 5,517 Million (Small Cap)
14.00
NA
0.00%
0.84
20.82%
2.63
Revenue and Profits:
Net Sales:
1,388 Million
(Quarterly Results - Dec 2025)
Net Profit:
141 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.8%
0%
-18.8%
6 Months
-15.62%
0%
-15.62%
1 Year
-25.52%
0%
-25.52%
2 Years
-63.88%
0%
-63.88%
3 Years
-50.0%
0%
-50.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Burjeel Holdings Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
459.59%
EBIT Growth (5y)
264.84%
EBIT to Interest (avg)
2.37
Debt to EBITDA (avg)
0.93
Net Debt to Equity (avg)
0.65
Sales to Capital Employed (avg)
1.56
Tax Ratio
10.63%
Dividend Payout Ratio
21.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10,508.23%
ROE (avg)
7,506.84%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
2.83
EV to EBIT
11.93
EV to EBITDA
7.47
EV to Capital Employed
1.99
EV to Sales
1.40
PEG Ratio
0.62
Dividend Yield
NA
ROCE (Latest)
16.72%
ROE (Latest)
20.82%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
1,387.60
1,304.90
6.34%
Operating Profit (PBDIT) excl Other Income
293.00
204.30
43.42%
Interest
44.30
46.20
-4.11%
Exceptional Items
1.20
0.00
Consolidate Net Profit
140.60
54.10
159.89%
Operating Profit Margin (Excl OI)
137.90%
78.70%
5.92%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 6.34% vs 7.15% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 159.89% vs -69.71% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
5,486.50
5,010.10
9.51%
Operating Profit (PBDIT) excl Other Income
1,030.60
897.00
14.89%
Interest
170.50
155.30
9.79%
Exceptional Items
73.00
2.10
3,376.19%
Consolidate Net Profit
502.60
360.30
39.49%
Operating Profit Margin (Excl OI)
117.60%
107.20%
1.04%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 9.51% vs 10.48% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 39.49% vs -33.33% in Dec 2024
About Burjeel Holdings Plc 
Burjeel Holdings Plc
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






